Clinical Trial

A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 17, 2025 (before its estimated November 26, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of Reduning Injection in the treatment of chikungunya fever
Trial Details
NCT Number NCT07126171
Lead Sponsor Jiangsu Kanion Pharmaceutical Co., Ltd
Conditions Chikungunya Fever
Enrollment 400 participants
Start Date 2025-08-28
Primary Completion 2025-11-26 (estimated)
Study Completion 2026-02-18 (estimated)
Updated on ClinicalTrials.gov 2025-08-17